TV Old timers probably remember the scene at the end of the Flintstones where Fred threw the sabertoothed tiger out of the house at nightfall. Turning the tables, the nasty critter jumps through the window, tosses Fred through the front door, and locks him out.
A different feline ticker symbol, Caterpillar (CAT), has been thrown out of a lot of investors’ portfolios in recent months. Today’s quarterly EPS of $1.45 (most analysts, such as Value Line and Yahoo Finance, expected closer to $1.68) and nearly 20% decline in revenues will keep this “cat” in the doghouse for a while.
But should it? Given the worldwide troubles in the mining sector, the decline in revenues was widely expected. But sales in China were a bright spot, up a sprightly 20% so far in 2013.
More importantly for long term investors, the steady drumbeat of bad news over the last three quarters has so far been unable to push the stock to new lows. Long term investors (and of course short ter m traders) should always be on the lookout for
Best Healthcare Technology Stocks To Watch For 2014: W&T Offshore Inc.(WTI)
W&T Offshore, Inc., an independent oil and natural gas producer, engages in the acquisition, exploration, and development of oil and natural gas properties primarily in the Gulf of Mexico. The company holds working interests in approximately 58 producing and 2 capable of producing offshore fields in federal and state waters. As of December 31, 2011, it had interests in offshore leases covering approximately 0.8 million gross acres in the coasts of Louisiana, Texas, Mississippi and Alabama, as well as onshore leasehold interest in approximately 0.2 million gross acres in Texas; proved reserves of 116.9 million barrels of oil equivalent (MMBoe); and proved undeveloped reserves of 40.5 MMBoe. The company was founded in 1983 and is headquartered in Houston, Texas.
- [By John Udovich]
Yesterday, small cap Energy XXI (Bermuda) Limited (NASDAQ: EXXI) announced a deal to acquire EPL Oil & Gas Inc (NYSE: EPL) to create the largest publicly held independent oil producer on the Gulf of Mexico shelf, meaning it might be a good idea to look at other small cap Gulf oil stocks like W&T Offshore, Inc (NYSE: WTI), Stone Energy Corporation (NYSE: SGY) and Contango Oil & Gas Company (NYSEMKT: MCF). Energy XXI’s CEO John Schiller has talked about the details of the acquisition with Jim Cramer on CNBC’s “Mad Money” and he noted that EPL Oil & Gas offers areas of expertise that EXXI currently lacks. However, investors who missed out on yesterday’s 29% surge for EPL Oil & Gas may want to check out these other small cap Gulf Oil stocks:
- [By Laura Brodbeck]
Notable earnings released on Friday included:
W&T Offshore(NYSE: WTI) reported a fourth quarter loss of $0.09 per share on revenue of $244.90 million, compared to last year’s EPS of $0.26 on revenue of $237.15 million. Footlocker(NYSE: FL) reported fourth quarter EPS of $0.82 on revenue of $1.79 billion, compared to last year’s EPS of $0.73 on revenue of $1.71 billion. Big Lots(NYSE: BIG) reported fourth quarter EPS of $1.39 on revenue of $1.64 billion, compared to last year’s EPS of $2.09 on revenue of $1.75 billion.
- [By Marc Bastow]
Independent oil and gas producer W&T Offshore (WTI) raised its quarterly dividend 11.1% to 10 cents per share, payable on Dec. 3 to shareholders of record as of Nov. 18.
WTI Dividend Yield: 2.25%
Best Healthcare Technology Stocks To Watch For 2014: Raven Industries Inc.(RAVN)
Raven Industries, Inc., together with its subsidiaries, manufactures various products for industrial, agricultural, energy, construction, and military/aerospace markets primarily in North America. It operates in four segments: Applied Technology, Engineered Films, Aerostar, and Electronic Systems. The Applied Technology segment designs, manufactures, sells, and services precision agriculture products and information management tools enabling growers to enhance farm yields. Its products include field computers, application controls, GPS-guidance and assisted-steering systems, automatic boom controls, and yield monitoring planter controls, as well as an integrated real time kinematic and information platform called Slingshot. This segment sells its products to original equipment manufacturers, as well as through after market distributors. The Engineered Films segment produces rugged reinforced plastic sheeting for industrial, construction, geomembrane, and agricultural appli cations. It sells plastic sheeting to independent third-party distributors through its sales force. The Aerostar segment sells high-altitude research balloons and tethered aerostats for government and commercial research. It produces military parachutes, uniforms, and protective wear for the U.S. government agencies as a subcontractor; and other sewn and sealed products on a contract basis. The Electronic Systems segment provides electronics manufacturing services for commercial customers. It manufactures assemblies, including avionics, communication, environmental controls, and other products. The company was founded in 1956 and is headquartered in Sioux Falls, South Dakota.
- [By Monica Gerson]
Raven Industries (NASDAQ: RAVN) is estimated to report its Q4 earnings at $0.32 per share on revenue of $97.14 million.
Vail Resorts (NYSE: MTN) is expected to post its Q2 earnings at $1.87 per share on revenue of $471.16 million.
- [By Dividends4Life]
Memberships and Peers: MMM is a member of the S&P 500, a Dividend Aristocrat, a member of the Broad Dividend Achievers™ Index and a Dividend Champion. The company’s peer group includes: General Electric Co. (GE) with a 3.1% yield, Raven Industries Inc. (RAVN) with a 1.6% yield and Carlisle Companies Inc. (CSL) with a 1.2% yield.
Best Healthcare Technology Stocks To Watch For 2014: Protalix Biotherapeutics Inc (PLX)
Protalix BioTherapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system, ProCellEx. Using its ProCellEx system, the Company is developing a pipeline of biosimilar or generic versions of recombinant therapeutic proteins based on its plant cell-based expression technology, which focuses pharmaceutical markets and that rely upon known biological mechanisms of action. ProCellEx protein expression system consists of a set of technologies and capabilities for the development of recombinant proteins, including advanced genetic engineering technology and plant cell-based protein expression methods. Its ProCellEx protein expression system is built on flexible custom-designed bioreactors made of polyethylene and optimized for the development of complex proteins in plant cell cultures. In June 2010, it had completed the preliminary phase I clinical trial of PRX- 105.
Taliglucerase alfa is a plant cell expressed recombinant glucocerebrosidase enzyme (GCD) for the treatment of Gaucher disease. The Company has commenced pre-clinical studies of an oral form of taliglucerase alfa. Its oral taliglucerase alfa is a plant cell expressed form of GCD that is naturally encapsulated within carrot cells genetically engineered to express the GCD enzyme. Pre-clinical studies of oral taliglucerase alfa demonstrate the stability of the enzyme in the cell and the capacity of the cell’s cellulose wall to protect the enzyme against degradation in the digestive tract in an in-vitro model of the stomach and intestines. Additionally, rats fed with lyophilized carrot cells expressing GCD have accumulated the active enzyme in the target organs; the spleen and liver. As of December 31, 2010, the Company had completed Phase III Clinical Trial.
The Company is developing PRX-102, i ts plant cell expressed modified version of the recombinant ! alpha-GAL-A protein, a therapeutic enzyme for the treatment of Fabry disease. Fabry disease is a rare, hereditary, genetic lysosomal storage disorder in humans caused by an X-lined deficiency of the alpha-GAL-A enzyme. The Company is in the animal evaluation testing phase of the development of PRX-102, which tests are based on a mouse model for Fabry disease.
Protalix Ltd. is a wholly owned subsidiary of the Company is licensed the rights to certain technology under a research and license agreement with Yissum Research and Development Company (Yissum) and the Boyce Thompson Institute, Inc. Pursuant to the agreement, the Company is developing PRX-105, a plant cell-based acetylcholinesterase (AChE) and its molecular variants for the use in several therapeutic and prophylactic indications, as well as in a biodefense program and an organophosphate-based pesticide treatment program.
As of December 31, 2010, its in-vitr o experiments of PRX-105 have shown that the acetylcholinesterase enzyme in its ProCellEx protein expression system demonstrates biological activity on biochemical and cellular levels. In addition, early animal studies demonstrated that the acetylcholinesterase expressed in its ProCellEx protein expression system was able to treat animals exposed to the nerve gas agent analogues, both when injected with its acetylcholinesterase product candidate immediately before exposure or when injected after exposure. In March 2010, it initiated a preliminary phase I clinical trial of PRX-105, which the Company completed in June 2010.
pr-antiTNF is a candidate for the treatment of certain autoimmune diseases such as rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing, spondylitis, psoriatic arthritis and plaque psoriasis. The Company has designed the antiTNF as pr-antiTNF. pr-antiTNF is a plant cell-expressed recombinant fusion protein ma de from the soluble form of the human TNF receptor (TNFR), f! used to t! he Fc component of a human antibody domain. pr-antiTNF has an identical amino acid sequence to Enbrel and its in-vitro and preclinical animal studies have demonstrated that pr-antiTNF exhibits similar activity to Enbrel. Specifically, pr-antiTNF binds TNF thereby inhibiting it from binding to cellular surface TNF receptors and protects L929 cells from TNF-induced apoptosis in a dose-dependent manner.
The Company competes with Genzyme, Actelion, Crucell N.V., Biolex, Inc., Chlorogen, Inc., Greenovation Biotech GmbH, Symbiosys, Novartis AG/Sandoz Pharmaceuticals, BioGeneriX AG, Stada Arzneimittel AG, BioPartners GmbH and Teva.
- [By Maxx Chatsko]
Industrial biotech isn’t the only industry headed to Brazil. Protalix (NYSEMKT: PLX ) entered into a technology transfer agreement with Brazil’s Ministry of Health last week that will pay the company $280 million. The deal is big news for Protalix’s first product, Elelyso/Uplyso, which was developed with partner Pfizer (NYSE: PFE ) . The treatment is approved as an enzyme replacement therapy, or ERT, for adults with type 1 Gaucher disease, and it marks a huge step forward for the future of biomanufacturing. In the following video, Fool contributor Maxx Chatsko explains what this means for the product’s commercialization and the adoption of Protalix’s novel plant cell-based expression system for therapeutic proteins.
- [By Keith Speights]
Other investors might wish that Pfizer would use some of its cash to acquire a few smaller companies. Protalix BioTherapeutics (NYSEMKT: PLX ) has been mentioned as one possible candidate. The two companies already partner together on Gaucher disease drug Elelyso. In February, Protalix spurred rumors that Pfizer could be interested in buying the company after it announced that it had engaged Citigroup to pursue a “broad array of strategic alternatives.”
Best Healthcare Technology Stocks To Watch For 2014: Cyan Inc (CYNI)
Cyan, Inc., incorporated on October 25, 2006, has carrier-grade networking solutions that transform legacy networks into open, high-performance networks. The Company’s solutions include high-capacity, multi-layer switching and transport platforms, as well as a carrier-grade software-defined networking platform and applications. The Company’s solutions enable network operators to virtualize their networks, accelerate service delivery. The Company has designed its solutions to provide a range of applications, including business Ethernet, Wireless and broadband support services and cloud connectivity. The Company also offer high-capacity, multi-layer switching and transport platforms, known as its Cyan Z-Series, that have been designed to support the multiple concurrent technologies used in regional and metro networks, including both Ethernet-based services, as well as optical services.
The Company’s Z-Series platforms have been designed to transport traff ic over network layer, utilizing both electrical and optical domains, to enable network operators to maximize network capacity at the lowest cost per bit. The Company’s customers range from service providers to high-performance data center and large, private network operators.
- [By Lauren Pollock]
Among the companies with shares expected to actively trade in Tuesday’s session are Cyan Inc.(CYNI), Neurocrine Biosciences Inc.(NBIX) and SandRidge Energy Inc.(SD)
Best Healthcare Technology Stocks To Watch For 2014: General Finance Corporation (GFN)
General Finance Corporation, through its subsidiaries, engages in the lease and sale of portable storage containers, portable container buildings, and freight containers. It offers mobile storage containers, including general purpose units, double pallet-wide high cube units, hazardous goods containers, and refrigerated containers; portable building containers, such as site offices and cabins, workforce accommodation units, luxury accommodation units, restroom blocks, blast-resistant units, and specialized office and infrastructure suites; and freight containers consisting of curtain-side containers, hi-cube containers, pallet-wide containers, side-opening door containers, and bulk containers. The company provides its products for various storage applications, including retail and manufacturing inventory, construction materials and equipment, documents and records, and household goods. It also leases and sells storage trailers and other storage structures, container office s, mobile offices, and modular buildings, as well as ancillary products comprising steps, furniture, portable toilets, security systems, and other items for use in connection with its equipment. In addition, the company offers delivery and installation, return and dismantle, and other site services. As of June 30, 2012, it operated a fleet of 23,855 mobile storage containers, 3,294 portable container buildings, and 9,348 freight containers. The company serves various industries, such as mining, road and rail, construction, moving and storage, manufacturing, transportation, defense, retail, utilities, education, and services sectors, as well as small and medium-size entities in New Zealand, North America, and the Asia-Pacific regions of Australia. General Finance Corporation was incorporated in 2005 and is headquartered in Pasadena, California.
- [By Lisa Levin]
General Finance (NASDAQ: GFN) shares touched a new 52-week high of $8.12 after DA Davidson lifted the price target on the stock from $8 to $11.
Mattress Firm Holding (NASDAQ: MFRM) shares reached a new 52-week high of $47.03 after the company reported upbeat Q4 earnings and raised its FY14 forecast.
Best Healthcare Technology Stocks To Watch For 2014: Star Gas Partners L.P.(SGU)
Star Gas Partners, L.P., through its subsidiaries, operates as a home heating oil distributor and services provider in the United States. It provides its services to residential and commercial customers to heat their homes and buildings. As of March 31, 2011, the company served approximately 408,000 full-service residential and commercial home heating oil, and propane customers. It also sold home heating oil, gasoline, and diesel fuel to approximately 40,000 customers. In addition, Star Gas Partners installed, maintained, and repaired heating and air conditioning equipment, as well as provided ancillary home services, including home security and plumbing to approximately 11,000 customers. Kestrel Heat, LLC operates as the general partner of the company. Star Gas Partners, L.P. was founded in 1995 and is headquartered in Stamford, Connecticut.
- [By Rich Smith]
Stamford, Conn.-based Star Gas Partners (NYSE: SGU ) is about to get a new CEO.
The company (which, despite the name, actually spends more time delivering oil than gas for home heating), announced Tuesday that Chief Executive Officer Dan Donovan intends to retire on Sept. 30. When that happens, Chief Operating Officer Steve Goldman will move up to take the CEO’s chair.
Best Healthcare Technology Stocks To Watch For 2014: First Financial Corporation Indiana(THFF)
First Financial Corporation, through its subsidiaries, provides various financial services. Its deposit products include interest-bearing and non-interest-bearing demand deposits, savings accounts, time deposits, and certificates of deposit. The company?s loan portfolio comprises commercial, financial, and agricultural loans; residential loans; and consumer loans. It also provides mortgage lending; lease financing; trust account and depositor services; and insurance services, such as property and casualty insurance, surety bonds, employee benefit plans, life insurance, and annuities. The company operates 54 branches in west-central Indiana and east-central Illinois. First Financial Corporation was founded in 1984 and is headquartered in Terre Haute, Indiana.
- [By Doug Hughes]
Doug Hughes: Sure, there is another one. The next one, the symbol would be (THFF). They’re in Indiana, a very large bank. First Federal Financial Corporation. Again, their book value is $27.
- [By James E. Brumley]
What do Prospect Capital Corporation (NASDAQ:PSEC), Astec Industries, Inc. (NASDAQ:ASTE), and First Financial Corp. (NASDAQ:THFF) have in common? Not much, on the surface. In fact, were it not for something very specific to one particular person (me), they’d have nothing in common at all. This week though, THFF, ASTE, and PSEC all have at least one thing in common, and that’s the fact that they’re all going into my mental/hypothetical portfolio.
Best Healthcare Technology Stocks To Watch For 2014: Seadrill Partners LLC (SDLP)
Seadrill Partners LLC (Seadrill Partners) is a limited liability company. The Company was formed to own, operate and acquire offshore drilling rigs. The Company’s drilling rigs are under long-term contracts with oil companies, such as Chevron, Total, BP and ExxonMobil with an average remaining term of 3.1 years as of June 30, 2012. The Company is also a holding company. The Company conducts its operations through its subsidiaries. In May 2013, SeaDrill Ltd sold T-15 tender rig to Seadrill Partners LLC
The Company’s wholly owned subsidiary, Seadrill Operating GP LLC, the general partner of Seadrill Operating LP, will manage Seadrill Operating LP’s operations and activities. The Company is also an international offshore drilling contractor.
- [By Robert Rapier]
Finally, international offshore drilling contractor Ocean Rig (Nasdaq: ORIG) has plans to drop down assets into an MLP in 2014. Seadrill Partners (NYSE: SDLP) is presently the only offshore driller structured as an MLP, and its rigs trade at a significant premium to those of Ocean Rig. Look for SEC filings related to this MLP during the second quarter.
- [By Aaron Levitt]
The key to SDRL has been its relationship with its master limited partnership subsidiary SeaDrill Partners (SDLP). SeaDrill has been quite successful at “dropping down” assets into SDLP to avoid taxes and gain hefty distributions. All of which continues to boost cash flows and dividend yields for SDRL stock.
Best Healthcare Technology Stocks To Watch For 2014: Enertopia Corp (ENRT)
Enertopia Corp (Enertopia), incorporated on November 24, 2004, is engaged in medicinal marijuana business. The Company is diverse in its pursuit of business opportunities in several sectors, including: Medicinal Marijuana, Oil and Gas, Solar PV (Photovoltaic), Solar Thermal (Hot Water), Energy Retrofits and Recovery, and Solar powered Filtered Drinking Water.
The Company no longer has any material oil and gas resources. The Company operates in two segments: renewable energy, and mining exploration and developments, which are managed separately based on fundamental differences in their operations nature.
- [By Peter Graham]
What’s the Catch With Lexaria Corp? According to various disclosures, a transaction or transactions of $1k has or will occur to mention Lexaria Corp in various investment newsletters. Last Friday, Lexaria Corp announced it had closed its Private Placement financing announced on March 5 for gross proceeds of $1,272,000 – higher than the originally announced $960,000 figure due to “overwhelming demand.” Lexaria Corp will issue 10,600,000 common shares at US$0.12 and 10,600,000 full warrants that expire on September 21, 2016 with an exercise price of US$0.25. However, the company may also accelerate the expiry date of the warrants if the stock price trades above CAD$0.40 cents for 20 consecutive days at any time after 6 months and one day has elapsed. Otherwise and in early March, Lexaria Corp reported that its board of directors had decided to make a strategic entry into the medical marijuana business by way of an “important Joint Venture” with Enertop ia Corp (OTCQB: ENRT). Under the terms of the Agreement, Lexaria Corp had agreed to pay Enertopia 1 million restricted common shares in return for Enertopia’s participation plus 500,000 restricted common shares ENRT’s Chairman in return for his participation on the Lexaria Advisory Board. Following the issuance of these shares, Lexaria Corp will have a total of 18,431,452 shares issued and outstanding and 21,256,452 shares fully diluted. A quick look at Lexaria Corp’s financials reveals revenues of $160k (most recent reported quarter), $241k, $251k and $253k for the past four quarters along with net losses of $102k (most recent reported quarter), $126k, $58k and $48k. At the end of last January, Lexaria Corp had $66k in cash to cover $1,415k in current liabilities and $59k in other liabilities. So aside from the income statement, investors might want to look more closely at Lexaria Corp’s financing terms.
Best Healthcare Technology Stocks To Watch For 2014: Post Properties Inc. (PPS)
Post Properties, Inc., a real estate investments trust (REIT), together with its subsidiaries, engages in the development, ownership, and management of multifamily apartment communities in the United States. As of December 31, 2007, the company owned 22,578 apartment units in 63 apartment communities, including 1,747 apartment units in 2 communities held in unconsolidated entities and 2,266 apartment units in 7 communities. It is also developing and selling 535 for-sale condominium homes in 4 communities and converting 349 apartment homes into for-sale condominium homes in 2 communities. The company primarily operates in Atlanta, Georgia; Dallas, Texas; Washington, D.C.; and Tampa, Florida metropolitan areas. Post Properties has elected to be taxed as REIT under the Internal Revenue Code and would not be subject to federal income taxes, if it distributes approximately 90% of its taxable income to its shareholders. The company was founded in 1971 and is based in Atlanta, Ge orgia.
- [By Sally Jones] ng>Rate of Return: 30.76%
Down 6% over 12 months, Post Properties Inc., a residential REIT, has a market cap of $2.46 billion; its shares were traded at around $45.02. The tangible book value is 20.98. PPS trades with a P/E ratio of 29.00 and a P/B of 2.10. The earnings yield is 2.80%.
Guru Action: As of Sept. 30, 2013, Third Avenue Management holds 422,734 shares values at around $20.9 million.
PPS is a relatively new holding for the firm, first bought in the second quarter of 2013. The firm bought 422,734 shares at an average price of $49.04, for a loss of 8.2%.
Track historical pricing, revenue and net income since 1993:
[ Enlarge Image ]
Valley National Bancorp (VLY)
Rate of Return: 26.4%
Up 5% over 12 months, Valley National Bancorp has a market cap of $2.07 billion; its shares were traded at around $10.40. The tangible book value is 5.28. VLY trades with a P/E ratio of 14.60 and a P/B of 1.30. The earnings yield is 3.80 %.
Guru Action: As of Sept. 30, 2013, Third Avenue Management holds 1,462,501 shares values at around $13.8 million.
VLY is another new holding for Third Avenue, first buying 1,462,501 shares in the second quarter of 2013, at an average price of $9.34, for a gain of 11.3%.
Track historical pricing, revenue and net income since 1990:
[ Enlarge Image ]
Brookdale Senior Living Inc. (BKD)
Rate of Return: 23.14%
Up 11% over 12 months, Brookdale Senior Living Inc. has a market cap of $3.35 billion; its shares were traded at around $26.94. The tangible book value is 5.97. BKD trades with a P/B of 3.30. The earnings yield is 1.80%.
Guru Action: As of Sept. 30, 2013, Third Avenue Management holds 658,866 shares values at around $17.429 million.
Bought in the second quarter of 2013, BKD is another new holding for Third Avenue. The firm made a new buy of 658,866 shares at an average price of $27.55, for a 2.2% loss.
Trac k historical pricing,